Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Loomis

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Lancet (London, England)|September 12, 2000
HIV-1 suppression during acute scrub-typhus infectionG Watt, P Kantipong, M de Souza, et al.
AIDS Research and Human Retroviruses|February 15, 2001
HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodiesV R Polonis, M S De Souza, P Chanbancherd, et al.
Geophysical Research Letters|June 16, 2015
GRGM900C: A degree 900 lunar gravity model from GRAIL primary and extended mission dataFrank G Lemoine, Sander Goossens, Terence J Sabaka, et al.
Drug and Chemical Toxicology|January 20, 1998
Assessment of health risks due to hazardous air pollutant emissions from electric utilitiesC French, W Peters, B Maxwell, et al.
AIDS Research and Human Retroviruses|December 31, 1998
HIV type 1 subtypes in Malaysia, determined with serologic assays: 1992-1996C Beyrer, T C Vancott, N K Peng, et al.
The Journal of Infectious Diseases|October 21, 1998
Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infectionL D Loomis-Price, J H Cox, J R Mascola, et al.
The Journal of Infectious Diseases|August 7, 1999
Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infectionS Sei, S L Sandelli, G Theofan, et al.
The Journal of Infectious Diseases|March 18, 2000
Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine InvestigatorsD L Birx, L D Loomis-Price, N Aronson, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Lancet (London, England)|September 12, 2000
HIV-1 suppression during acute scrub-typhus infectionG Watt, P Kantipong, M de Souza, et al.
AIDS Research and Human Retroviruses|February 15, 2001
HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodiesV R Polonis, M S De Souza, P Chanbancherd, et al.
Geophysical Research Letters|June 16, 2015
GRGM900C: A degree 900 lunar gravity model from GRAIL primary and extended mission dataFrank G Lemoine, Sander Goossens, Terence J Sabaka, et al.
Drug and Chemical Toxicology|January 20, 1998
Assessment of health risks due to hazardous air pollutant emissions from electric utilitiesC French, W Peters, B Maxwell, et al.
AIDS Research and Human Retroviruses|December 31, 1998
HIV type 1 subtypes in Malaysia, determined with serologic assays: 1992-1996C Beyrer, T C Vancott, N K Peng, et al.
The Journal of Infectious Diseases|October 21, 1998
Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infectionL D Loomis-Price, J H Cox, J R Mascola, et al.
The Journal of Infectious Diseases|August 7, 1999
Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infectionS Sei, S L Sandelli, G Theofan, et al.
The Journal of Infectious Diseases|March 18, 2000
Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine InvestigatorsD L Birx, L D Loomis-Price, N Aronson, et al.
Pageof 9